Category Archives: THE FUTURE OF LLLT

My vision of the future for LLLT

James Carroll’s Congress speech on ending opioid use with Photobiomodulation

A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in health care, direct health care costs and lost productivity because of pain.

49,000 people from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.

We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.

Learn more at CongressPBM.com

Watch the Congressional Briefing Highlight Video

Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com

Posted in Industry, James in Action, THE FUTURE OF LLLT, Video of the Week | Leave a comment

Building NovoTHOR: It starts with Quality components

Making a NovoTHOR starts with designing and manufacturing quality components. Testing occurs throughout the build process to ensure the NovoTHOR meets strict requirements for light distribution and dose for maximum effectiveness.

More NovoTHOR Testimonials | NovoTHOR Treatment Locations

View current photobiomodulation therapy training dates in your location.

Posted in THE FUTURE OF LLLT, Video of the Week | Leave a comment

Building NovoTHOR: Made in the USA

We make NovoTHOR in the USA, working with experts in LED manufacturing who have a passion for excellence. They implement testing and quality systems to ensure every aspect is built to our high standards.

More NovoTHOR Testimonials | NovoTHOR Treatment Locations

View current photobiomodulation therapy training dates in your location.

Posted in Industry, THE FUTURE OF LLLT, Video of the Week | Leave a comment

THOR laser in UK National Health Service (NHS) clinical trial for treatment of Oral Mucositis

Laser therapy to ease cancer treatment side effects | ITV News

MPH LiTFORM ITV news release Sept 2018

Read more on Photobiomodulation Therapy for reducing severity and duration of oral mucositis.

Posted in Industry, THE FUTURE OF LLLT, Video of the Week | Leave a comment

Shining a Light on PBM & The Health Care Innovation Ecosystem

By Ms. Hannah M Clark, Global NetGeneration of Youth Cyberjournalist, with support from Dr. Ronnie Lowenstein, Executive Director Global NetGeneration of Youth

NGY Cyberjournalist Hannah Clark being inspired by the passion of Mr. James Carroll, founder and CEO of THOR Medicine.Recently, I was honored to be invited by Dr. Robert Boege, Executive Director of ASTRA to join ASTRA’s Futurist Dr. Ronnie Lowenstein, and serve as a NetGeneration of Youth Cyberjournalist covering a Congressional Briefing held in the Rayburn House Office Building on October 11, 2018 entitled, “Ending Opioid Use: A New Hope”.  The event was co-sponsored by ASTRA, The World Association for Laser Therapy, NetGeneration of Youth, The Optical Society of America, and thirteen other science and medical organizations.  What an opportunity to learn about PBM, “photobiomodulation,” an innovative medical technology, as well as, to be exposed to the organizational stakeholders who advocate for support of America’s ‘science and technology innovation ecosystem.’

What is PBM and What does it Promise?
When I first heard the term photobiomodulation (PBM) I was confused—initially the word sounded like a lighting … Continue reading

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

New Technologies, Treatments Can End Opioid Use

Those suffering from America’s opioid crisis recently received two major messages of hope.

On Oct. 24, President Donald Trump signed the Opioid Crisis Response Act (OCRA) into law. Dozens of bills designed to address the diverse aspects of the opioid crisis were consolidated into one strategic and integrated approach.

OCRA received overwhelming bi-partisan support in both Chambers.

HR6, which is now Public Law 115-2716, broke new ground in being the first legislation to mandate aggressive development and adoption of alternative pain treatments that include “innovative medical technologies for pain management.”

On Oct. 11, Congress held its first ever briefing on ending opioid use through “innovative medical technologies for pain management.”

Photobiomodulation (PBM) was the featured technology.

Read the full news story on newsmax.com

Posted in Industry, THE FUTURE OF LLLT | Leave a comment

THOR CEO leads official US Congressional Briefing on Photobiomodulation (PBM)

Washington DC, 11th October, 2018. James Carroll (CEO, THOR Photomedicine), Prof. Praveen Arany (University at Buffalo, NY), Annette Quinn RN (Program Manager, Radiation Oncology, University of Pittsburgh (UPMC) Cancer Center) introduced Photobiomodulation (PBM) to a large gathering of senior policy officials at the Rayburn House Office Building.

James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.

The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.

The panel outlined the needs for PBM adoption as

  1. Research grants to fund further basic science experiments, therapeutic dose, and large multicenter clinical trials.
  2. FDA to create a PBM specific product code.
  3. Public and private health insurance reimbursement.

For … Continue reading

Posted in Industry, THE FUTURE OF LLLT | Leave a comment